about
Immunomodulatory interventions for focal epilepsy syndromesImmunomodulatory interventions for focal epilepsy syndromesEpilepsy and innate immune system: A possible immunogenic predisposition and related therapeutic implicationsOxidative stress and epilepsy: literature reviewA role for leukocyte-endothelial adhesion mechanisms in epilepsyTonicity-responsive enhancer binding protein haplodeficiency attenuates seizure severity and NF-κB-mediated neuroinflammation in kainic acid-induced seizures.Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice.Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.Development of postinfection epilepsy after Theiler's virus infection of C57BL/6 mice.Anticonvulsant activity of bone marrow cells in electroconvulsive seizures in mice.Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection.Homocysteine Induced Cerebrovascular Dysfunction: A Link to Alzheimer's Disease EtiologyRole of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy.A Large-Scale Study Indicates Increase in the Risk of Epilepsy in Patients With Different Risk Factors, Including Rheumatoid ArthritisProtein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokinesInfiltrating macrophages are key to the development of seizures following virus infection.Immature dentate gyrus: an endophenotype of neuropsychiatric disorders.Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy.Role of hormones and neurosteroids in epileptogenesis.The role of interleukin-1beta in febrile seizures.The cortical innate immune response increases local neuronal excitability leading to seizures.B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity.Immune therapy in autism: historical experience and future directions with immunomodulatory therapy.Emerging drugs for focal epilepsy.Potential pharmacological strategies for the improved treatment of organophosphate-induced neurotoxicity.Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.Epileptogenesis due to glia-mediated synaptic scaling.Effect of minocycline on pentylenetetrazol-induced chemical kindled seizures in mice.Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation.Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus.Th17 cells in depression.Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro.Interictal encephalography can influence patient selection for methylprednisolone therapy in pediatric refractory epilepsy.Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy.
P2860
Q24201788-29C101F8-8A2E-4194-BA3B-A3C931AC6191Q24202238-419DF360-BAA2-4FA8-A03E-08CE6B973CA0Q26799604-AE0C047A-C9EF-46FC-98B0-4CC2705DDDEDQ26996304-49BFDECB-48BC-4737-B1BB-FD117DB809FDQ30488791-4A490C75-D59A-4D53-8D57-349902CBE8DCQ30595791-CE56CECA-8D51-4FA3-90D6-8654F0C8481CQ30850543-EF78BFD1-450F-4805-BB65-480F5C7EDF56Q34238657-81F4353C-3D71-43A8-B654-6C5373EA026AQ34795870-23DE0624-1E70-440A-9F8B-04B807DB4924Q34980422-1890975F-311D-4D50-A083-A63E5FE6D974Q35077723-396C9901-B224-4EC7-A12C-3229786DA712Q35796970-1655DFA1-5776-48C0-88BA-B4687A4EB9C0Q35971997-1D5C06A5-1FDE-48C5-B940-84AA3687DA47Q36194833-335B6F54-C8BC-4BE4-92B9-EB04D6DFF7AFQ36372950-A8D6561E-C096-43EC-B9CB-2B721B12A2BFQ36559966-306ABFF9-8BD9-4927-96BE-2FD54B0D489AQ36960113-8684B93E-8E1C-42FD-8123-11D0C85EDC75Q37010478-444CB0D0-B70F-4F8E-AA1D-00574BD31295Q37057683-DCCE412C-8A2A-4C4A-9691-CD9892FEDA0AQ37235731-30C3944E-3C5B-424C-8B57-982BA1185FE8Q37319554-BF471409-38A4-48FD-A8A0-77B684081DDBQ37429555-7C61EB2C-D94D-467E-9D80-BC7496594CB9Q37774098-1552AE0D-C2CA-40B7-99C5-ABF1BDC293F9Q38062011-ADA1C157-8F2F-449F-871B-DDB5500AA2A1Q38263071-3EE161A5-670E-4C30-9171-0D112AE9B2EAQ38425098-409E6798-A3FB-45A1-87E2-4AC944FF58DAQ38728679-D5A3992F-A4F1-4E61-A9D5-EC522E60D1B5Q39126886-06B39EF0-1129-412C-8E65-34B52E8F7489Q39657680-ABA34B88-57F9-4228-BE11-25540FA4B4BCQ44523984-7189C72F-AFB5-4774-8609-F207D9DF8F97Q45821604-E30E2797-19AD-4FF3-A967-5191092602F9Q47736252-AB321450-31A0-4706-B0AA-ACC4DCC7A6E0Q47805738-638D2396-6373-45F3-9C92-3D7EB01BC9EAQ48228365-E8981AA6-A0D1-465B-97FB-4DDA722B9D7AQ48924170-1CC3B2E8-88A7-498D-8B2F-EB560871B3A9Q49090389-042F2715-3833-40F9-9DD4-A81576F3A276
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Inflammation and epilepsy
@en
type
label
Inflammation and epilepsy
@en
prefLabel
Inflammation and epilepsy
@en
P2860
P1433
P1476
Inflammation and epilepsy
@en
P2860
P356
10.1111/J.1535-7597.2005.05101.X
P407
P577
2005-01-01T00:00:00Z